Navigation Links
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
Date:11/26/2014

DUBLIN, Nov. 25, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences. 

  • 31st NASDAQ Investor Program in London, UK on Tuesday, December 2, 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain McGill, senior vice president and head of EUSA International, will provide an overview of the company and a business and financial update.
  • 26th Annual Piper Jaffray Healthcare Conference in New York, NY on Tuesday, December 2, 2014 at 2:00 p.m. EST / 7:00 p.m. GMT. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update.

A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs. The company has a diverse portfolio of products and/or product candidates in the areas of sleep, hematology/oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Versacloz® (clozapine) oral suspension, FazaClo® (clozapine, USP) HD and FazaClo LD. Jazz Pharmaceuticals also has a number of products marketed outside the United States, including Erwinase® and Defitelio® (defibrotide). For more information, please visit www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2018)... FREDERICK, Md. (PRWEB) , ... September 01, 2018 , ... ... infections like Lyme disease, will be hosting the Getting Rid of Lyme Disease Issues ... Frederick Innovative Technology Center Inc. (FITCI) , Lyme Disease is the number one vector ...
(Date:9/1/2018)... (PRWEB) , ... September 01, 2018 , ... ... Inc. ( Shaw ) focuses on the company’s continued efforts to “Create a ... to healthier environments and preservation of natural resources. , “2017 was a ...
(Date:8/31/2018)... ... August 31, 2018 , ... Many ... such as medications for cancer, mental health and required blood clotting agents used ... Respiratory Distress Syndroms (RDS) in premature babies and can be cost prohibitive – ...
Breaking Medicine Technology:
(Date:8/31/2018)... RAPIDS, Mich. (PRWEB) , ... August 31, 2018 ... ... treatment provider, will host an Open House on Wednesday, September 12 from 1:00-3:00 ... options available in Grand Rapids, as well as tour the facility, meet our ...
(Date:8/31/2018)... ... 31, 2018 , ... The social impact documentary feature film on homelessness, OFF ... NIH-funded researcher Luciana Lagana, aka Dr. Luciana, has been faring well at film ... Film Festival, IndieFEST Film Awards, Shawna Shea Memorial Film Festival, and Top Indie Film ...
(Date:8/31/2018)... ... August 31, 2018 , ... Nitro Circus hosted the inaugural A Night to ... action sports gathering to celebrate the life of Erik Roner, world-renowned skier, skydiver and ... wife, Annika and their two small children, Oskar (8) and Kasper (4). A portion ...
(Date:8/31/2018)... , ... August 31, 2018 , ... ... of South Jersey Gastroenterology for another year. Dr. Savon has been active in ... the leaders in comprehensive care for all gastrointestinal diseases and disorders for the ...
(Date:8/31/2018)... ... 31, 2018 , ... ZPower, the world’s only developer of ... Chief Information Officer. Arneja previously served as Director of Information Systems and in ... optimize, scale, and innovate the business. , Prior to joining ZPower, Arneja ...
Breaking Medicine News(10 mins):